Are These On Your List Of Penny Stocks To Buy Right Now?
Whether you’re looking for penny stocks to buy right now or ones to put on a watch list, a strategy is needed. A rule of thumb is to have some idea of why a stock is moving. Observing things like technical levels and understanding the type of trading momentum in play is also quite important.
A news headline might be one of the biggest a company has released. But if there’s no trading momentum that follows, there’s little opportunity to make money with that stock. Regardless, not all penny stocks with news are ones worth buying. At the same time, not all penny stocks breaking out are worth chasing.
Read More
- Can You Make Money With Penny Stocks? 5 To Watch Today
- 4 Penny Stocks To Watch As Entertainment Stocks Capture Spotlight
This brings me to my next point: what type of trader are you? Do you day trade penny stocks? Are you more of a swing trader or do you look for way to invest in penny stocks? All of these have different strategies to implement and time frames to take into consideration. If you’re looking for some of the top penny stocks traders are buying today, the following list has a few active names right now.
Given the fact that so many new traders are using apps like Webull and Robinhood to buy penny stocks, these are all trading on major exchanges. This is an important thing to take account of. All too often do we see a lack of liquidity in things like OTC penny stocks. That’s generally due to the fact that major firms are unable to trade those types of stocks. But depending on the type of trader or investor you are, will they be the best penny stocks to buy today? I’ll leave that up to you to decide.
Robinhood Penny Stocks To Buy [or avoid]: Sio Gene Therapies Inc.
Sio Gene Therapies Inc. (SIOX Stock Report) is the new company name of Axovant Gene Therapies (f/k/a AXGT). Earleir this quarter, the company rebranded to Sio Gene Therapies to reflect a company with a scientific strategy focused on disease-modifying and curative genetic medicines.
The new company continues developing gene therapies and the current AXO-AAV0GM1 treatment. It’s currently being dosed in patients with GM1 gangliosidosis. This trial is expected to have some topline data from the lower dose cohort by the end of the year.
Aside from this info, there haven’t been many new headlines this month. So as investors await more data, SIOX stock has begun aggressively climbing higher this week. Volume is the highest the stock has seen since the name and symbol change. What’s more, is that SIOX stock broke back above $3 for the first time since October.
Robinhood Penny Stocks To Buy [or avoid]: Geovax Labs Inc.
Geovax Labs (GOVX Stock Report) was among the low float penny stocks to watch this month. December 7th to the 9th, GVAX stock screamed to highs of $7.50 from just $2.80. Positive news surrounding COVID-19 vaccine stocks appeared to help give the penny stock that boosts earlier in the month. However, this week there is something concrete to point to for recent momentum in GVAX stock.
This morning, the company’s CEO appeared on FOX Business. He explained that the company is seeking federal funding to accelerate its vaccine program. Furthermore, The Geovax CEO also explained that the company is taking a “broader viral approach” to single-dose coronavirus vaccines.
[Read More] 4 Hot Penny Stocks To Watch Right Now If You Like Tech & Biotech Stocks
New traders just seeing Geovax for the first time should also keep something else in mind. At the end of November the company signed a Patent and Biological Materials License Agreement with the National Institute of Allergy and Infectious Diseases. This is to support the company’s non-clinical development of pathogen-fighting vaccines.
Robinhood Penny Stocks To Buy [or avoid]: Sunworks Inc.
With the recent confirmation of Joe Biden as President of the United States this week, traders have begun watching renewables and alternative energy stocks. Aside from electric vehicle stocks today, solar energy stocks are also pushing the envelope during Tuesday’s session.
Sunworks Inc. (SUNW Stock Report) has been one of the solar energy stocks to watch for the better part of the last few months. In fact, since we wrote the article, “Did These Low Float Penny Stocks Make The Cut This Week?” you could say SUNW been one of the solar stocks shining this year. From July 1st to this week, shares have moved from $0.99 to highs of $4.45 so far this week. What’s more, is that SUNW stock managed to reach highs of $8.50.
The company develops solar power solutions for agricultural, commercial, industrial, and residential markets. You might remember that it had canceled a prior merger agreement with another solar company, Peck, earlier this quarter. That seemed to have triggered the start of this latest rally we’re seeing in Q4. This month the company completed a $20 million raise and managed to pay off $2.7 million in old debt. What else should you know about Sunworks heading into 2021? The company has experienced strong growth this year, specifically in its third quarter. The company reported $10 million in sales for the quarter. On top of that, some of its Q3 sales contributed to the build-out of parking canopies that would include EV charging stations. Thanks to the hype surrounding EV right now, could that add some sympathy strength to the latest move?
Robinhood Penny Stocks To Buy [or avoid]: Jaguar Health Inc.
Shares of Jaguar Health Inc. (JAGX Stock Report) have been on fire this month. We’ve been discussing the company for the better part of the last few weeks in light of recent events in the company. It looks like those events have turned heads more aggressively heading into the second half of December. What’s funny is that despite missing earnings, JAGX stock has found other means of executing on its shareholder initiatives.
[Read More] 4 Penny Stocks To Watch Before 2021 & 2 Jumped Over 200% In Q4
Specifically, the company is focusing on its pipeline treatments. Jaguar and its subsidiary, Napo Pharmaceuticals announced last week that the duo is planning to study, develop, and commercialize crofelemer. This is a proprietary drug for an indication of inflammatory diarrhea. Specifically, Jaguar’s focusing on the emergence of “long-hauler COVID-19-recovery patients.”
Traders looking at JAGX stock right now should be aware of what’s happening this week. Thursday the company hosts an investor call before the open. Jaguar plans to discuss all developments that have taken place thus far. Also keep in mind that the company is holding preliminary discussions with Swiss Growth Forum, a sponsor of a European special purpose acquisition company, “Post Pandemic Recovery Equity”. There’s a potential deal with the SPAC and an operational subsidiary of Jaguar to be established in Europe with an exclusive license to crofelemer and Mytesi for the indications of inflammatory diarrhea and HIV-related diarrhea.
